Stock market candidate ISX Financial EU PLC: These are the differences between BankTech and FinTech
The digital transformation of banks is in full swing and BankTech and FinTech companies are bringing movement and competitive pressure to the market with their offerings. New technology trends are coming onto the market at an ever-increasing pace, while security, regulatory and data protection aspects must be taken into account during development. The ISXPlc Group is an important global player in this BankTech field: it operates in more than 34 countries, accepts more than 40 payment methods and enables the processing and settlement of transactions in more than 23 currencies. But what exactly distinguishes BankTech companies such as ISX Financial EU Plc ("ISXPlc"; ISIN: CY0200861017) from other FinTech companies?
BankTech vs. FinTech
Both BankTech and FinTech are likely to play an important role in the future development of the financial sector. However, while BankTech mainly focuses on improving and optimizing internal processes of traditional banks, FinTech aims to revolutionize financial services for end customers and bring new entrants into the financial sector. Both areas overlap to a certain extent, as traditional banks are also increasingly implementing FinTech solutions in order to remain competitive.
Products and partnerships
The market potential for BankTech is significant as banks continue to look for ways to increase efficiency, reduce costs and increase customer satisfaction. ISXPlc contributes to this by providing cross-border solutions for customer enrollment, remote identity verification, payment processing, card acquisition, settlement and eMoney issue and redemption. ISXPlc develops its own "banking technology" via its wholly owned Probanx® subsidiary, which it uses to provide regulated services, and then converts it into a SaaS (Software as a Service) that other banks and payment companies can use. Probanx® provides technical aggregation and gateway services for financial institutions to access the UK’s Faster Payment Service, as well as to the (Central) Bank of Lithuania’s CentroLink service for SEPA Instant, SEPA SCT and SEP SDD, and is finalizing access agreements with other Central banks in the MENA and European region.
The integration of advanced core banking platforms such as Probanx® CorePlus enables banks to improve their services while meeting regulatory requirements. In addition, the growing acceptance of digital solutions and the need for secure and efficient processing of financial transactions signals an increasing demand for BankTech solutions.
Collaborations with Mastercard (ISIN: US57636Q1040) for card acquisition and Diners Discover Financial Services (ISIN: US2547091080) for card issuing illustrate ISXPlc's strategic goals to enter new markets and offer innovative financial products. Learn more about the technology and vision driving ISXPlc and discover the future of BankTech in the video interview with Nikogiannis Karantzis, Managing Director and CEO of ISXPlc: https://www.isx.financial/blog/nkinterviewdrreuter
----------
Subscribe to the mailing list for ISX Financial or second-line stocks. Simply send an e-mail to Eva Reuter: [email protected] with the reference: "Distribution list ISX Financial " or "Secondary stocks".
ISX Financial
Disclaimer/risk warning
Conflicts of interest: There is a paid IR and PR contract with ISX Financial. The content of the services is, among other things, to increase the level of awareness of the company. Dr. Reuter Investor Relations is therefore acting in the interests of ISX Financial in the preparation and distribution of this article. It is a promotional editorial presentation.
Corporate risks: As with any company, there are risks relating to the implementation of the business model. There is no guarantee that the business model can be implemented as planned.
Investment risks: Investments should only be made with funds that are freely available and not required to secure a livelihood. There is no guarantee that it will be possible to sell the shares on the stock exchange at any time. In principle, shares are always subject to the risk of total loss.
Disclaimer: All information published in this newsletter / article is based on careful research. The information does not constitute an offer to sell the share(s) in question or a solicitation to buy or sell securities. The information is based on sources that the publisher considers trustworthy.
Sources: In particular, information available on the company website is taken into account for the presentation assessment of the companies. As a rule, there is also direct contact with the Executive Board / IR team of the respective company analyzed or presented. The article was submitted to ISX Financial prior to publication in order to have the accuracy of all information checked.
Forward-looking statements
This release contains certain forward-looking statements, including statements about the Company. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words or similar words or phrases have been used to identify these forward-looking statements. These statements reflect the author's current views and are based on information available to the author as of the date of this report.
Forward-looking statements involve substantial risks, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from those discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on forward-looking statements. Although the forward-looking statements contained in this press release are based on assumptions that the author believes to be reasonable, readers cannot be assured that actual results will be consistent with these forward-looking statements. Dr. Reuter Investor Relations undertakes no obligation to update or revise these statements to reflect new events or circumstances, except as required by law.
Responsible contact for queries
Dr. Reuter Investor Relations
Dr. Eva Reuter
Friedrich-Ebert-Anlage 35-37
60327 Frankfurt
+49 (0) 69 1532 5857
Please address inquiries to: [email protected]
